Depression and Related Psychological Factors in Heart Disease

REFERENCES

• Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997;349:1498–504.
   PubMed Web of Science ®Google Scholar
• Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998;155:4–11.
   PubMed Web of Science ®Google Scholar
• Hance M, Carney RM, Freedland KE, Skala J. Depression in patients with coronary heart disease. A 12-month follow-up. Gen Hosp Psychiatry 1996;18:61–5.
   PubMed Web of Science ®Google Scholar
• Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med 1989;149:1785–9.
   PubMed Web of Science ®Google Scholar
• Carney R, Freedland K, Steinmeyer B, et al. Depression and five year survival following acute myocardial infarction: a prospective study. J Affect Disord 2008;109:133–8.
   PubMed Web of Science ®Google Scholar
• Frasure-Smith N, Lesperance F. Depression and coronary artery disease. Herz 2006;31 suppl 3:64–8.
   PubMed Web of Science ®Google Scholar
• Forrester AW, Lipsey JR, Teitelbaum ML, DePaulo JR, Andrzejewski PL. Depression following myocardial infarction. Int J Psychiatry Med 1992;22:33–46.
   PubMed Web of Science ®Google Scholar
• Lesperance F, Frasure-Smith N, Juneau M, Theroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000;160:1354–60.
   PubMed Web of Science ®Google Scholar
• Blumenthal JA, Lett HS, Babyak MA, et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003;362:604–9.
   PubMed Web of Science ®Google Scholar
• Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP. Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet 2001;358:1766–71.
   PubMed Web of Science ®Google Scholar
• Jiang W. Impacts of depression and emotional distress on cardiac disease. Cleve Clin J Med 2008;75 suppl 2:S20–5.
   PubMedGoogle Scholar
• Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095–105.
   PubMed Web of Science ®Google Scholar
• Carney RM, Freedland KE, Jaffe AS. Insomnia and depression prior to myocardial infarction. Psychosom Med 1990;52:603–9.
   PubMedGoogle Scholar
• Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993;270:1819–25.
   PubMed Web of Science ®Google Scholar
• Malzberg B. Mortality among patients with involution melancholia. Am J Psychiatry 1937;93:1231–8.
   Google Scholar
• Weeke A. Causes of death in manic-depressives. In: Schou M, Stromgren E, eds. Origin, prevention and treatment of affective disorders. London: Academic, 1979.
   Google Scholar
• Tsuang MT, Woolson RF, Fleming JA. Premature deaths in schizophrenia and affective disorders. An analysis of survival curves and variables affecting the shortened survival. Arch Gen Psychiatry 1980;37:979–83.
   PubMed Web of Science ®Google Scholar
• Norton B, Whalley LJ. Mortality of a lithium-treated population. Br J Psychiatry 1984;145:277–82.
   PubMed Web of Science ®Google Scholar
• Rabins PV, Harvis K, Koven S. High fatality rates of late-life depression associated with cardiovascular disease. J Affect Disord 1985;9:165–7.
   PubMed Web of Science ®Google Scholar
• Murphy JM, Monson RR, Olivier DC, Sobol AM, Leighton AH. Affective disorders and mortality. A general population study. Arch Gen Psychiatry 1987;44:473–80.
   PubMed Web of Science ®Google Scholar
• Penninx BW, Geerlings SW, Deeg DJ, van Eijk JT, van Tilburg W, Beekman AT. Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry 1999;56:889–95.
   PubMed Web of Science ®Google Scholar
• Penninx BW, Beekman AT, Honig A, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001;58:221–7.
   PubMed Web of Science ®Google Scholar
• Ariyo AA, Haan M, Tangen CM, et al. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation 2000;102:1773–9.
   PubMed Web of Science ®Google Scholar
• Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Arch Intern Med 2000;160:1261–8.
   PubMed Web of Science ®Google Scholar
• Anda R, Williamson D, Jones D, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 1993;4:285–94.
   PubMed Web of Science ®Google Scholar
• Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med 2002;23:51–61.
   PubMed Web of Science ®Google Scholar
• Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 2003;65:201–10.
   PubMed Web of Science ®Google Scholar
• Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91:999–1005.
   PubMed Web of Science ®Google Scholar
• Frasure-Smith N, Lesperance F. Depression and other psychological risks following myocardial infarction. Arch Gen Psychiatry 2003;60:627–36.
   PubMed Web of Science ®Google Scholar
• Lesperance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 2002;105:1049–53.
   PubMed Web of Science ®Google Scholar
• van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004;66:814–22.
   PubMedGoogle Scholar
• Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004;66:802–13.
   PubMed Web of Science ®Google Scholar
• Frasure-Smith N, Lesperance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry 2008;65:62–71.
   PubMed Web of Science ®Google Scholar
• Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006;48:1527–37.
   PubMed Web of Science ®Google Scholar
• Dickens C, McGowan L, Percival C, et al. New onset depression following myocardial infarction predicts cardiac mortality. Psychosom Med 2008;70:450–5.
   PubMed Web of Science ®Google Scholar
• Parker GB, Hilton TM, Walsh WF, et al. Timing is everything: the onset of depression and acute coronary syndrome outcome. Biol Psychiatry 2008;64:660–6.
   PubMed Web of Science ®Google Scholar
• Rosenman R, Brand R, Jenkins C, Friedman M, Straus R, Moses W. Coronary heart disease in the Western Collaborative Group Study: final follow-up experience of 8½ years. JAMA 1975;233:872–7.
   PubMed Web of Science ®Google Scholar
• Friedman M, Thoresen C, Gill J, et al. Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project. Am Heart J 1986;112:653–65.
   PubMed Web of Science ®Google Scholar
• Booth-Kewley S, Friedman HS. Psychological predictors of heart disease: a quantitative review. Psychol Bull 1987;101:343–62.
   PubMed Web of Science ®Google Scholar
• Shekelle R, Gale M, Ostfeld A, Paul O. Hostility, risk of coronary heart disease, and mortality. Psychosom Med 1983;45:109–14.
   PubMed Web of Science ®Google Scholar
• Shekelle RB, Hulley SB, Neaton JD, et al. The MRFIT behavior pattern study. II. Type A behavior and incidence of coronary heart disease. Am J Epidemiol 1985;122:559–70.
   PubMed Web of Science ®Google Scholar
• Brondolo E, Rieppi R, Erickson S, et al. Hostility, interpersonal interactions, and ambulatory blood pressure. Psychosom Med 2003;65:1003–11.
   PubMed Web of Science ®Google Scholar
• Sloan R, Shapiro P, Bigger J, Bagiella E, Steinman R, Gorman J. Cardiac autonomic control and hostility in healthy subjects. Am J Cardiol 1994;74:298–300.
   PubMed Web of Science ®Google Scholar
• Markovitz J. Hostility is associated with increased platelet activation in coronary artery disease. Psychosom Med 1998;60:586–91.
   PubMed Web of Science ®Google Scholar
• Iribarren C, Sidney S, Bild D, et al. Association of hostility with coronary artery calcification in young adults. The CARDIA Study. JAMA 2000;283:2546–51.
   PubMed Web of Science ®Google Scholar
• Barefoot J, Larsen S, Von der Lieth L, Schroll M. Hostility, incidence of acute myocardial infarction, and mortality in a sample of older Danish men and women. Am J Epidemiol 1995;142:477–84.
   PubMed Web of Science ®Google Scholar
• Siegman A, Wolfe, Townsend S, Civelek C, Blumenthal R. Antagonistic behavior, dominance, hostility, and coronary heart disease. Psychosom Med 2000;62:248–57.
   PubMedGoogle Scholar
• Williams J, Paton C, Siegler I, Eigenbrodt M, Nieto F, Tyroler H. Anger proneness predicts coronary heart disease risk. Prospective analysis from the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2000;101:2034–9.
   PubMed Web of Science ®Google Scholar
• Schulman J, Stromberg S. On the value of doing nothing. Anger and cardiovascular disease in clinical practice. Cardiol Rev 2007;15:123–32.
   PubMedGoogle Scholar
• Booth-Kewley S, Friedman HS. Psychological predictors of heart disease: a quantitative review. Psychol Bull 1987;101:343–62.
   PubMed Web of Science ®Google Scholar
• Ketterer MW, Huffman J, Lumley MA, et al. Five-year follow-up for adverse outcomes in males with at least minimally positive angiograms: importance of “denial” in assessing psychosocial risk factors. J Psychosom Res 1998;44:241–50.
   PubMed Web of Science ®Google Scholar
• Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 2005;67:89–97.
   PubMed Web of Science ®Google Scholar
• Denollet J, Sys S, Stroobant N, Rombouts H, Gillebert T, Brutsaert D. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 1996;347:417–21.
   PubMed Web of Science ®Google Scholar
• Denollet J, Pedersen SS, Ong AT, Erdman RA, Serruys PW, van Domburg RT. Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era. Eur Heart J 2006;27:171–7.
   PubMed Web of Science ®Google Scholar
• Denollet J, Martens E, Nyklícek I, Conraads V, de Gelder B. Clinical events in coronary patients who report low distress: adverse effect of repressive coping. Health Psychol 2008;27:302–8.
   PubMed Web of Science ®Google Scholar
• Kop WJ, Appels AP, Mendes de Leon CF, Bar FW. The relationship between severity of coronary artery disease and vital exhaustion. J Psychosom Res 1996;40:397–405.
   PubMed Web of Science ®Google Scholar
• Appels A, Mulder P. Excess fatigue as a precursor of myocardial infarction. Eur Heart J 1988;9:758–64.
   PubMed Web of Science ®Google Scholar
• Bages N, Appels A, Falger PR. Vital exhaustion as a risk factor of myocardial infarction: a case-control study in Venezuela. Int J Behav Med 1999;6:279–90.
   PubMed Web of Science ®Google Scholar
• Appels A, Mulder P. Fatigue and heart disease. The association between 'vital exhaustion' and past, present and future coronary heart disease. J Psychosom Res 1989;33:727–38.
   PubMed Web of Science ®Google Scholar
• Schuitemaker GE, Dinant GJ, Van Der Pol GA, Appels A. Assessment of vital exhaustion and identification of subjects at increased risk of myocardial infarction in general practice. Psychosomatics 2004;45:414–8.
   PubMed Web of Science ®Google Scholar
• Appels A, Bar F, Van Der Pol G, et al. Effects of treating exhaustion in angioplasty patients on new coronary events: results of the randomized Exhaustion Intervention Trial (EXIT). Psychosom Med 2005;67:217–23.
   PubMed Web of Science ®Google Scholar
• Kawachi I, Colditz G, Ascherio A, et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994;89:1992–7.
   PubMed Web of Science ®Google Scholar
• Kawachi I, Sparrow D, Vokonas P, Weiss S. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994;90:2225–9.
   PubMed Web of Science ®Google Scholar
• Huffman JC, Smith FA, Blais MA, Januzzi JL, Fricchione GL. Anxiety, independent of depressive symptoms, is associated with in-hospital cardiac complications after acute myocardial infarction. J Psychosom Res 2008;65:557–63.
   PubMed Web of Science ®Google Scholar
• Smoller JW, Pollack MH, Wassertheil-Smoller S, et al. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Arch Gen Psychiatry 2007;64:1153–60.
   PubMed Web of Science ®Google Scholar
• Kubzansky LD, Kawachi I, Spiro A 3rd, Weiss ST, Vokonas PS, Sparrow D. Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study. Circulation 1997;95:818–24.
   PubMed Web of Science ®Google Scholar
• Moser DK, Riegel B, McKinley S, Doering LV, An K, Sheahan S. Impact of anxiety and perceived control on in-hospital complications after acute myocardial infarction. Psychosom Med 2007;69:10–6.
   PubMed Web of Science ®Google Scholar
• Sullivan MD, LaCroix AZ, Spertus JA, Hecht J. Five-year prospective study of the effects of anxiety and depression in patients with coronary artery disease. Am J Cardiol 2000;86:1135–8, A6, A9.
   PubMedGoogle Scholar
• Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry 2008;65:1324–30.
   PubMed Web of Science ®Google Scholar
• Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:953–62.
   PubMed Web of Science ®Google Scholar
• Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005;352:539–48.
   PubMed Web of Science ®Google Scholar
• Wittstein IS. The broken heart syndrome. Cleve Clin J Med 2007;74 suppl 1:S17–22.
   Google Scholar
• O'Reardon JP, Lott JP, Akhtar UW, Cristancho P, Weiss D, Jones N. Acute coronary syndrome (Takotsubo cardiomyopathy) following electroconvulsive therapy in the absence of significant coronary artery disease: case report and review of the literature. J ECT 2008;24:277–80.
   PubMedGoogle Scholar
• Leor J, Kloner RA. The Northridge earthquake as a trigger for acute myocardial infarction. Am J Cardiol 1996;77:1230–2.
   PubMed Web of Science ®Google Scholar
• Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med 1996;334:413–9.
   PubMed Web of Science ®Google Scholar
• Wilbert-Lampen U, Leistner D, Greven S, et al. Cardiovascular events during World Cup soccer. N Engl J Med 2008;358:475–83.
   PubMed Web of Science ®Google Scholar
• Steinberg JS, Arshad A, Kowalski M, et al. Increased incidence of life-threatening ventricular arrhythmias in implantable defibrillator patients after the World Trade Center attack. J Am Coll Cardiol 2004;44:1261–4.
   PubMed Web of Science ®Google Scholar
• Shedd OL, Sears SF Jr, Harvill JL, et al. The World Trade Center attack: increased frequency of defibrillator shocks for ventricular arrhythmias in patients living remotely from New York City. J Am Coll Cardiol 2004;44:1265–7.
   PubMed Web of Science ®Google Scholar
• Musselman DL, Marzec UM, Manatunga A, et al. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry 2000;57:875–82.
   PubMed Web of Science ®Google Scholar
• Laghrissi-Thode F, Wagner WR, Pollock BG, Johnson PC, Finkel MS. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997;42:290–5.
   PubMed Web of Science ®Google Scholar
• Musselman DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996;153:1313–7.
   PubMed Web of Science ®Google Scholar
• Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998;55:580–92.
   PubMed Web of Science ®Google Scholar
• Pollock BG, Laghrissi-Thode F, Wagner WR. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol 2000;20:137–40.
   PubMed Web of Science ®Google Scholar
• Sauer W, Berlin J, Kimmel S. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 2001;104:1894–8.
   PubMed Web of Science ®Google Scholar
• Sauer W, Berlin J, Kimmel S. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation 2003;108:32–6.
   PubMed Web of Science ®Google Scholar
• Cohen H, Gibson G, Alderman M. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 2000;108:2–8.
   PubMed Web of Science ®Google Scholar
• Tata L, West J, Smith C, et al. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart 2005;91:465–71.
   PubMed Web of Science ®Google Scholar
• Monster T, Johnsen S, Olsen M, McLaughlin J, Sorensen H. Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study. Am J Med 2004;117:732–7.
   PubMedGoogle Scholar
• Meier C, Schlienger R, Jick H. Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. Br J Clin Pharmacol 2001;52:179–84.
   PubMed Web of Science ®Google Scholar
• Allen MT, Patterson SM. Hemoconcentration and stress: a review of physiological mechanisms and relevance for cardiovascular disease risk. Biol Psychol 1995;41:1–27.
   PubMedGoogle Scholar
• Patterson SM, Krantz DS, Gottdiener JS, Hecht G, Vargot S, Goldstein DS. Prothrombotic effects of environmental stress: changes in platelet function, hematocrit, and total plasma protein. Psychosom Med 1995;57:592–9.
   PubMedGoogle Scholar
• Muldoon MF, Herbert TB, Patterson SM, Kameneva M, Raible R, Manuck SB. Effects of acute psychological stress on serum lipid levels, hemoconcentration, and blood viscosity. Arch Intern Med 1995;155:615–20.
   PubMedGoogle Scholar
• de Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh JH. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 1990;81:107–17.
   PubMedGoogle Scholar
• Wong ML, Dong C, Esposito K, et al. Elevated stress-hemoconcentration in major depression is normalized by antidepressant treatment: secondary analysis from a randomized, double-blind clinical trial and relevance to cardiovascular disease risk. PLoS ONE 2008;3:e2350.
   Google Scholar
• Glassman AH. Cigarette smoking: implications for psychiatric illness. Am J Psychiatry 1993;150:546–53.
   PubMed Web of Science ®Google Scholar
• Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000;160:1818–23.
   PubMed Web of Science ®Google Scholar
• Kronish IM, Rieckmann N, Halm EA, et al. Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med 2006;21:1178–83.
   PubMed Web of Science ®Google Scholar
• Whooley M, de Jonge P, Vittinghoff E. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008;300:2379–88.
   PubMed Web of Science ®Google Scholar
• Rieckmann N, Gerin W, Kronish IM, et al. Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study. J Am Coll Cardiol 2006;48:2218–22.
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135–43.
   PubMed Web of Science ®Google Scholar
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685–95.
   PubMed Web of Science ®Google Scholar
• Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71:171–86.
   PubMed Web of Science ®Google Scholar
• Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002;90:1279–83.
   PubMed Web of Science ®Google Scholar
• Parissis JT, Adamopoulos S, Rigas A, et al. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol 2004;94:1326–8.
   PubMed Web of Science ®Google Scholar
• Piletz JE, Halaris A, Iqbal O, et al. Pro-inflammatory biomakers in depression: treatment with venlafaxine. World J Biol Psychiatry 2008 Dec 31:1–11.
   Google Scholar
• Moorman AJ, Mozaffarian D, Wilkinson CW, et al. In patients with heart failure elevated soluble TNF-receptor 1 is associated with higher risk of depression. J Card Fail 2007;13:738–43.
   PubMedGoogle Scholar
• Whooley MA, Caska CM, Hendrickson BE, Rourke MA, Ho J, Ali S. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry 2007;62:314–20.
   PubMed Web of Science ®Google Scholar
• Davidson KW, Schwartz JE, Kirkland SA, et al. Relation of inflammation to depression and incident coronary heart disease (from the Canadian Nova Scotia Health Survey [NSHS95] Prospective Population Study). Am J Cardiol 2009;103:755–61.
   PubMedGoogle Scholar
• Bigger J, Fleiss J, Steinman R, Rolnitzky L, Kleiger R, Rottman J. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164–71.
   PubMed Web of Science ®Google Scholar
• Bigger J, Fleiss J, Rolnitzky L, Steinman R. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol 1993;21:729–36.
   PubMed Web of Science ®Google Scholar
• Carney RM, Blumenthal JA, Stein PK, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001;104:2024–8.
   PubMed Web of Science ®Google Scholar
• Carney RM, Blumenthal JA, Freedland KE, et al. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med 2005;165:1486–91.
   PubMedGoogle Scholar
• Giardina EG, Barnard T, Johnson L, Saroff AL, Bigger JT Jr, Louie M. The antiarrhythmic effect of nortriptyline in cardiac patients with ventricular premature depolarizations. J Am Coll Cardiol 1986;7:1363–9.
   PubMed Web of Science ®Google Scholar
• Morganroth J, Goin JE. Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysis. Circulation 1991;84:1977–83.
   PubMed Web of Science ®Google Scholar
• Roose SP, Glassman AH, Dalack GW. Depression, heart disease, and tricyclic antidepressants. J Clin Psychiatry 1989;50 suppl:12–6; discussion 17.
   PubMedGoogle Scholar
• Strik JJ, Honig A, Lousberg R, et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med 2000;62:783–9.
   PubMed Web of Science ®Google Scholar
• Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701–9.
   PubMed Web of Science ®Google Scholar
• Carney RM, Blumenthal JA, Freedland KE, et al. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med 2004;66:466–74.
   PubMed Web of Science ®Google Scholar
• Taylor CB, Youngblood ME, Catellier D, et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry 2005;62:792–8.
   PubMed Web of Science ®Google Scholar
• Lesperance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007;297:367–79.
   PubMed Web of Science ®Google Scholar
• Honig A, Kuyper AM, Schene AH, et al. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. Psychosom Med 2007;69:606–13.
   PubMed Web of Science ®Google Scholar
• Mohapatra PK, Kar N, Kar GC, Behera M. Effectiveness of sertraline in treatment of depression in a consecutive sample of patients with acute myocardial infarction: six month prospective study on outcome. Clin Pract Epidemol Ment Health 2005;1:26.
   PubMedGoogle Scholar
• Lesperance F, Frasure-Smith N, Laliberte MA, et al. An open-label study of nefazodone treatment of major depression in patients with congestive heart failure. Can J Psychiatry 2003;48:695–701.
   PubMedGoogle Scholar
• Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT, Giardina EG. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry 1991;148:512–6.
   PubMed Web of Science ®Google Scholar
• Johnson EM, Whyte E, Mulsant BH, et al. Cardiovascular changes associated with venlafaxine in the treatment of late-life depression. Am J Geriatr Psychiatry 2006;14:796–802.
   PubMed Web of Science ®Google Scholar
• Rigotti NA, Thorndike AN, Regan S, et al. Bupropion for smokers hospitalized with acute cardiovascular disease. Am J Med 2006;119:1080–7.
   PubMed Web of Science ®Google Scholar
• Shapiro P. Psychopharmacology in cardiac disease. In: Ferrando S, Levenson J, Robinson M, Owen J, eds. Handbook of psychopharmacology in the medically ill. Washington, DC: American Psychiatric Publishing, 2009.
   Google Scholar